Preview

Clinical and experimental thyroidology

Advanced search

Natural Course of Subclinical Hypothyroidism

https://doi.org/10.14341/ket20051143-47

Abstract

Objectives of this retrospective study were to evaluate the natural course of subclinical hypothyroidism (SH) and to estimate possible predictable factors of overt hypothyroidism. Population of the study was selected from the patients with spontaneously elevated thyrotropin (TSH) and normal free thyroxin (fT4) levels. Overall 87 patients (12 male, 75 female) with SH without any therapy with thyroid hormones or iodide drugs or without previous thyroid surgery, thyrostatic therapy, or radioactive iodine therapy were included in the analysis. Results: the main risk factors of overt hypothyroidism in this population were positive thyroid antibodies (odds ratio = 3.99) and high initial level of TSH (>8 mU/l) (odds ratio = 4.77). Patient’s age, gender or duration of SH did not affect significantly the risk of overt hypothyroidism. Conclusions: rational substitutive therapy with thyroid hormones was not discussed in this study, however the data suggest that positive thyroid antibodies and relatively high TSH level may be useful to decide upon such therapy in individuals with SH. Key words: hypothyroidism, Hashimotos, thyroiditis, thyrotropin.

About the Authors

J Sytch

Department of Endocrinology of Moscow Medical Academy


V. Fadeev

Department of Endocrinology of Moscow Medical Academy


G Melnichenko

Department of Endocrinology of Moscow Medical Academy


References

1. Фадеев В.В., Мельниченко Г.А. Гипотиреоз. 2-е изд. Москва: Соверо Пресс. 2004.

2. Bindels A.J., Westendorp R.G., Frolich M. et al. The prevalence of sub-clinical hypothyroidism at different total plasma cholesterol levels in middle aged men and women: a need for case-finding? // Clin. Endocrinol. (Oxf). 1999. V. 50. P. 217-220.

3. Fatourechi V., Lankarani M., Schryver P.G. et al. Factors influencing clinical decisions to initiate thyroxine therapy for patients with mildly increased serum thyrotropin (5,1 - 10,0 mIU/L) // Mayo Clin. Proc. 2003. V. 78. P. 554-560.

4. Huber G., Staub J.J., Meier C. et al. Preospective study of the spontaneous course of subclinical hypothyroidism; prognostic value of thyrotropin, thyroid reserve and thyroid antibodies // J. Clin. Endocrinol. Metab. 2002. V. 87. P. 3221-3226.

5. Lerch M., Meier C., Staub J.J. Is there a need for treatment in sub-clinical hypo- and hyperthyroidism? // Ther. Umsch. 1999. V. 56. P. 369-373.

6. Nystroem E., Caidahl K., Fager G. et al. A double-blind cross-over 12-month study of L-thyroxine treatment of women with subclinical hypothyroidism. // Clin. Endocrinol. (Oxf.). 1988. V. 29. P. 63-75.

7. Vanderpump M.P., Tunbridge W.-M.G., French J.M. et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Wickham Survey. // Clin. Endocrinol. 1995. V. 43. P. 55-68.


Review

For citations:


 ,  ,   Natural Course of Subclinical Hypothyroidism. Clinical and experimental thyroidology. 2005;1(1):43-47. https://doi.org/10.14341/ket20051143-47

Views: 433


ISSN 1995-5472 (Print)
ISSN 2310-3787 (Online)